MDB CAPITAL HOLDINGS LLC - CLASS A COMMON

New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market

01 Apr 2025 10:00:00 By Nasdaq GlobeNewswire

MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update

31 Mar 2025 16:05:00 By Nasdaq GlobeNewswire

MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time

24 Mar 2025 08:50:00 By Nasdaq GlobeNewswire

New PatentVest Pulse Report Reveals Transformative Trends in the AI Data Center Patent Race

05 Mar 2025 10:00:00 By Nasdaq GlobeNewswire

eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering

19 Feb 2025 08:25:00 By Nasdaq GlobeNewswire

Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes

12 Feb 2025 08:50:00 By Nasdaq GlobeNewswire

Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol

10 Feb 2025 11:00:00 By Nasdaq GlobeNewswire

Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change

07 Jan 2025 10:00:00 By Nasdaq GlobeNewswire

MDB Capital Holdings Provides Third Quarter 2024 Update

21 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities

19 Nov 2024 09:05:00 By Nasdaq GlobeNewswire

MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern Time

15 Nov 2024 09:05:00 By Nasdaq GlobeNewswire

Invizyne Technologies Announces Closing of Initial Public Offering

14 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing

13 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Invizyne Technologies Begins Trading on NASDAQ

13 Nov 2024 09:05:00 By Nasdaq GlobeNewswire

Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024

12 Nov 2024 10:52:00 By Nasdaq GlobeNewswire

Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering

11 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

MDB Capital Teams with TCA Venture Group to Bring New Insights and Public Venture Opportunities to Angel Investors

16 Oct 2024 12:02:55 By Nasdaq GlobeNewswire

MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies

11 Jul 2024 16:05:00 By Nasdaq GlobeNewswire

Recently Published Whitepaper from PatentVest Delves into Transformative Innovations in MASH Diagnostics

09 Jul 2024 11:00:00 By Nasdaq GlobeNewswire

MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform

08 Jul 2024 16:16:31 By Nasdaq GlobeNewswire